Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cue Biopharma (CUE) Other Non Operating Income (2018 - 2020)

Cue Biopharma (CUE) has disclosed Other Non Operating Income for 3 consecutive years, with -$23000.0 as the latest value for Q3 2020.

  • Quarterly Other Non Operating Income fell 560.0% to -$23000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$56922.0 through Sep 2020, down 139.71% year-over-year, with the annual reading at $64078.0 for FY2019, 61.24% down from the prior year.
  • Other Non Operating Income hit -$23000.0 in Q3 2020 for Cue Biopharma, up from -$26000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $98000.0 in Q3 2018 to a low of -$26000.0 in Q1 2020.
  • Historically, Other Non Operating Income has averaged $18041.5 across 3 years, with a median of $3500.0 in 2018.
  • Biggest five-year swings in Other Non Operating Income: surged 4700.0% in 2019 and later crashed 560.0% in 2020.
  • Year by year, Other Non Operating Income stood at $66337.0 in 2018, then crashed by 119.48% to -$12922.0 in 2019, then crashed by 77.99% to -$23000.0 in 2020.
  • Business Quant data shows Other Non Operating Income for CUE at -$23000.0 in Q3 2020, -$26000.0 in Q1 2020, and -$12922.0 in Q4 2019.